Sanduja P, Schmieder S, Baddal B, Tian S, Velarde J, Lencer W
mBio. 2025; 16(3):e0377724.
PMID: 39835825
PMC: 11898750.
DOI: 10.1128/mbio.03777-24.
Tabata A, Matsumoto A, Fujimoto A, Ohkura K, Ikeda T, Oda H
J Oral Microbiol. 2022; 14(1):2105013.
PMID: 35937899
PMC: 9351568.
DOI: 10.1080/20002297.2022.2105013.
Johnstone B, Joseph R, Christie M, Morton C, McGuiness C, Walsh J
IUBMB Life. 2022; 74(12):1169-1179.
PMID: 35836358
PMC: 9712165.
DOI: 10.1002/iub.2661.
Shah N, Voisin T, Parsons E, Boyd C, Hoogenboom B, Bubeck D
Nat Commun. 2020; 11(1):5818.
PMID: 33199689
PMC: 7669874.
DOI: 10.1038/s41467-020-19482-6.
Shewell L, Day C, Jen F, Haselhorst T, Atack J, Reijneveld J
Sci Adv. 2020; 6(21):eaaz4926.
PMID: 32494740
PMC: 7244308.
DOI: 10.1126/sciadv.aaz4926.
From Normal Flora to Brain Abscesses: A Review of .
Issa E, Salloum T, Tokajian S
Front Microbiol. 2020; 11:826.
PMID: 32457718
PMC: 7221147.
DOI: 10.3389/fmicb.2020.00826.
Cholesterol-Dependent Cytolysins Produced by Vaginal Bacteria: Certainties and Controversies.
Pleckaityte M
Front Cell Infect Microbiol. 2020; 9:452.
PMID: 31998661
PMC: 6966277.
DOI: 10.3389/fcimb.2019.00452.
Membrane Binding, Cellular Cholesterol Content and Resealing Capacity Contribute to Epithelial Cell Damage Induced by Suilysin of .
Votsch D, Willenborg M, Oelemann W, Brogden G, Valentin-Weigand P
Pathogens. 2020; 9(1).
PMID: 31905867
PMC: 7168673.
DOI: 10.3390/pathogens9010033.
Pharmacological Targeting of Pore-Forming Toxins as Adjunctive Therapy for Invasive Bacterial Infection.
Escajadillo T, Nizet V
Toxins (Basel). 2018; 10(12).
PMID: 30562923
PMC: 6316385.
DOI: 10.3390/toxins10120542.
Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.
Haapasalo K, Wollman A, de Haas C, van Kessel K, van Strijp J, Leake M
FASEB J. 2018; 33(3):3807-3824.
PMID: 30509126
PMC: 6404581.
DOI: 10.1096/fj.201801910R.
Cholesterol-dependent cytolysins: from water-soluble state to membrane pore.
Christie M, Johnstone B, Tweten R, Parker M, Morton C
Biophys Rev. 2018; 10(5):1337-1348.
PMID: 30117093
PMC: 6233344.
DOI: 10.1007/s12551-018-0448-x.
Disentangling the roles of cholesterol and CD59 in intermedilysin pore formation.
Boyd C, Parsons E, Smith R, Seddon J, Ces O, Bubeck D
Sci Rep. 2016; 6:38446.
PMID: 27910935
PMC: 5133593.
DOI: 10.1038/srep38446.
Structural Basis for Receptor Recognition by the Human CD59-Responsive Cholesterol-Dependent Cytolysins.
Lawrence S, Gorman M, Feil S, Mulhern T, Kuiper M, Ratner A
Structure. 2016; 24(9):1488-98.
PMID: 27499440
PMC: 5320943.
DOI: 10.1016/j.str.2016.06.017.
The Unique Molecular Choreography of Giant Pore Formation by the Cholesterol-Dependent Cytolysins of Gram-Positive Bacteria.
Tweten R, Hotze E, Wade K
Annu Rev Microbiol. 2015; 69:323-40.
PMID: 26488276
PMC: 7875328.
DOI: 10.1146/annurev-micro-091014-104233.
Dual modes of membrane binding direct pore formation by Streptolysin O.
Mozola C, Caparon M
Mol Microbiol. 2015; 97(6):1036-50.
PMID: 26059530
PMC: 4692278.
DOI: 10.1111/mmi.13085.
The Cholesterol-dependent Cytolysin Membrane-binding Interface Discriminates Lipid Environments of Cholesterol to Support β-Barrel Pore Insertion.
Farrand A, Hotze E, Sato T, Wade K, Wimley W, Johnson A
J Biol Chem. 2015; 290(29):17733-17744.
PMID: 26032415
PMC: 4505022.
DOI: 10.1074/jbc.M115.656769.
Perfringolysin O: The Underrated Clostridium perfringens Toxin?.
Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Haesebrouck F
Toxins (Basel). 2015; 7(5):1702-21.
PMID: 26008232
PMC: 4448169.
DOI: 10.3390/toxins7051702.
The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59.
Zilnyte M, Venclovas C, Zvirbliene A, Pleckaityte M
Toxins (Basel). 2015; 7(1):110-28.
PMID: 25590277
PMC: 4303817.
DOI: 10.3390/toxins7010110.
Reconstitution of cholesterol-dependent vaginolysin into tethered phospholipid bilayers: implications for bioanalysis.
Budvytyte R, Pleckaityte M, Zvirbliene A, Vanderah D, Valincius G
PLoS One. 2013; 8(12):e82536.
PMID: 24349307
PMC: 3862629.
DOI: 10.1371/journal.pone.0082536.
Vaginolysin drives epithelial ultrastructural responses to Gardnerella vaginalis.
Randis T, Zaklama J, LaRocca T, Los F, Lewis E, Desai P
Infect Immun. 2013; 81(12):4544-50.
PMID: 24082080
PMC: 3837968.
DOI: 10.1128/IAI.00627-13.